Global Rotavirus Infections Drug Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Rotavirus Infections Drug will have significant change from previous year. According to our (LP Information) latest study, the global Rotavirus Infections Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Rotavirus Infections Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Rotavirus Infections Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rotavirus Infections Drug market, reaching US$ million by the year 2028. As for the Europe Rotavirus Infections Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Rotavirus Infections Drug players cover Beijing Minhai Biotechnology Co Ltd, Bharat Biotech International Ltd, Biological E Ltd, and Curevac AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rotavirus Infections Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Rotavirus Infections Drug will have significant change from previous year. According to our (LP Information) latest study, the global Rotavirus Infections Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Rotavirus Infections Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Rotavirus Infections Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rotavirus Infections Drug market, reaching US$ million by the year 2028. As for the Europe Rotavirus Infections Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Rotavirus Infections Drug players cover Beijing Minhai Biotechnology Co Ltd, Bharat Biotech International Ltd, Biological E Ltd, and Curevac AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rotavirus Infections Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- RV-3BB
- RV-625
- UMN-2001
- Rotavac-5C
- Others
- Clinic
- Hospital
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Beijing Minhai Biotechnology Co Ltd
- Bharat Biotech International Ltd
- Biological E Ltd
- Curevac AG
- Medicago Inc
- Nanotherapeutics Inc
- Serum Institute of India Ltd
- UMN Pharma Inc
- Wuhan Institute of Biological Products Co Ltd
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rotavirus Infections Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Rotavirus Infections Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Rotavirus Infections Drug by Country/Region, 2017, 2022 & 2028
2.2 Rotavirus Infections Drug Segment by Type
2.2.1 RV-3BB
2.2.2 RV-625
2.2.3 UMN-2001
2.2.4 Rotavac-5C
2.2.5 Others
2.3 Rotavirus Infections Drug Sales by Type
2.3.1 Global Rotavirus Infections Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Rotavirus Infections Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Rotavirus Infections Drug Sale Price by Type (2017-2022)
2.4 Rotavirus Infections Drug Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 Others
2.5 Rotavirus Infections Drug Sales by Application
2.5.1 Global Rotavirus Infections Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Rotavirus Infections Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Rotavirus Infections Drug Sale Price by Application (2017-2022)
3 GLOBAL ROTAVIRUS INFECTIONS DRUG BY COMPANY
3.1 Global Rotavirus Infections Drug Breakdown Data by Company
3.1.1 Global Rotavirus Infections Drug Annual Sales by Company (2020-2022)
3.1.2 Global Rotavirus Infections Drug Sales Market Share by Company (2020-2022)
3.2 Global Rotavirus Infections Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Rotavirus Infections Drug Revenue by Company (2020-2022)
3.2.2 Global Rotavirus Infections Drug Revenue Market Share by Company (2020-2022)
3.3 Global Rotavirus Infections Drug Sale Price by Company
3.4 Key Manufacturers Rotavirus Infections Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rotavirus Infections Drug Product Location Distribution
3.4.2 Players Rotavirus Infections Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ROTAVIRUS INFECTIONS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Rotavirus Infections Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Rotavirus Infections Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Rotavirus Infections Drug Annual Revenue by Geographic Region
4.2 World Historic Rotavirus Infections Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Rotavirus Infections Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Rotavirus Infections Drug Annual Revenue by Country/Region
4.3 Americas Rotavirus Infections Drug Sales Growth
4.4 APAC Rotavirus Infections Drug Sales Growth
4.5 Europe Rotavirus Infections Drug Sales Growth
4.6 Middle East & Africa Rotavirus Infections Drug Sales Growth
5 AMERICAS
5.1 Americas Rotavirus Infections Drug Sales by Country
5.1.1 Americas Rotavirus Infections Drug Sales by Country (2017-2022)
5.1.2 Americas Rotavirus Infections Drug Revenue by Country (2017-2022)
5.2 Americas Rotavirus Infections Drug Sales by Type
5.3 Americas Rotavirus Infections Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rotavirus Infections Drug Sales by Region
6.1.1 APAC Rotavirus Infections Drug Sales by Region (2017-2022)
6.1.2 APAC Rotavirus Infections Drug Revenue by Region (2017-2022)
6.2 APAC Rotavirus Infections Drug Sales by Type
6.3 APAC Rotavirus Infections Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rotavirus Infections Drug by Country
7.1.1 Europe Rotavirus Infections Drug Sales by Country (2017-2022)
7.1.2 Europe Rotavirus Infections Drug Revenue by Country (2017-2022)
7.2 Europe Rotavirus Infections Drug Sales by Type
7.3 Europe Rotavirus Infections Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rotavirus Infections Drug by Country
8.1.1 Middle East & Africa Rotavirus Infections Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Rotavirus Infections Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Rotavirus Infections Drug Sales by Type
8.3 Middle East & Africa Rotavirus Infections Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rotavirus Infections Drug
10.3 Manufacturing Process Analysis of Rotavirus Infections Drug
10.4 Industry Chain Structure of Rotavirus Infections Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rotavirus Infections Drug Distributors
11.3 Rotavirus Infections Drug Customer
12 WORLD FORECAST REVIEW FOR ROTAVIRUS INFECTIONS DRUG BY GEOGRAPHIC REGION
12.1 Global Rotavirus Infections Drug Market Size Forecast by Region
12.1.1 Global Rotavirus Infections Drug Forecast by Region (2023-2028)
12.1.2 Global Rotavirus Infections Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rotavirus Infections Drug Forecast by Type
12.7 Global Rotavirus Infections Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Beijing Minhai Biotechnology Co Ltd
13.1.1 Beijing Minhai Biotechnology Co Ltd Company Information
13.1.2 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product Offered
13.1.3 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Beijing Minhai Biotechnology Co Ltd Main Business Overview
13.1.5 Beijing Minhai Biotechnology Co Ltd Latest Developments
13.2 Bharat Biotech International Ltd
13.2.1 Bharat Biotech International Ltd Company Information
13.2.2 Bharat Biotech International Ltd Rotavirus Infections Drug Product Offered
13.2.3 Bharat Biotech International Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bharat Biotech International Ltd Main Business Overview
13.2.5 Bharat Biotech International Ltd Latest Developments
13.3 Biological E Ltd
13.3.1 Biological E Ltd Company Information
13.3.2 Biological E Ltd Rotavirus Infections Drug Product Offered
13.3.3 Biological E Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Biological E Ltd Main Business Overview
13.3.5 Biological E Ltd Latest Developments
13.4 Curevac AG
13.4.1 Curevac AG Company Information
13.4.2 Curevac AG Rotavirus Infections Drug Product Offered
13.4.3 Curevac AG Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Curevac AG Main Business Overview
13.4.5 Curevac AG Latest Developments
13.5 Medicago Inc
13.5.1 Medicago Inc Company Information
13.5.2 Medicago Inc Rotavirus Infections Drug Product Offered
13.5.3 Medicago Inc Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Medicago Inc Main Business Overview
13.5.5 Medicago Inc Latest Developments
13.6 Nanotherapeutics Inc
13.6.1 Nanotherapeutics Inc Company Information
13.6.2 Nanotherapeutics Inc Rotavirus Infections Drug Product Offered
13.6.3 Nanotherapeutics Inc Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Nanotherapeutics Inc Main Business Overview
13.6.5 Nanotherapeutics Inc Latest Developments
13.7 Serum Institute of India Ltd
13.7.1 Serum Institute of India Ltd Company Information
13.7.2 Serum Institute of India Ltd Rotavirus Infections Drug Product Offered
13.7.3 Serum Institute of India Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Serum Institute of India Ltd Main Business Overview
13.7.5 Serum Institute of India Ltd Latest Developments
13.8 UMN Pharma Inc
13.8.1 UMN Pharma Inc Company Information
13.8.2 UMN Pharma Inc Rotavirus Infections Drug Product Offered
13.8.3 UMN Pharma Inc Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 UMN Pharma Inc Main Business Overview
13.8.5 UMN Pharma Inc Latest Developments
13.9 Wuhan Institute of Biological Products Co Ltd
13.9.1 Wuhan Institute of Biological Products Co Ltd Company Information
13.9.2 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product Offered
13.9.3 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Wuhan Institute of Biological Products Co Ltd Main Business Overview
13.9.5 Wuhan Institute of Biological Products Co Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Rotavirus Infections Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Rotavirus Infections Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Rotavirus Infections Drug by Country/Region, 2017, 2022 & 2028
2.2 Rotavirus Infections Drug Segment by Type
2.2.1 RV-3BB
2.2.2 RV-625
2.2.3 UMN-2001
2.2.4 Rotavac-5C
2.2.5 Others
2.3 Rotavirus Infections Drug Sales by Type
2.3.1 Global Rotavirus Infections Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Rotavirus Infections Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Rotavirus Infections Drug Sale Price by Type (2017-2022)
2.4 Rotavirus Infections Drug Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 Others
2.5 Rotavirus Infections Drug Sales by Application
2.5.1 Global Rotavirus Infections Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Rotavirus Infections Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Rotavirus Infections Drug Sale Price by Application (2017-2022)
3 GLOBAL ROTAVIRUS INFECTIONS DRUG BY COMPANY
3.1 Global Rotavirus Infections Drug Breakdown Data by Company
3.1.1 Global Rotavirus Infections Drug Annual Sales by Company (2020-2022)
3.1.2 Global Rotavirus Infections Drug Sales Market Share by Company (2020-2022)
3.2 Global Rotavirus Infections Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Rotavirus Infections Drug Revenue by Company (2020-2022)
3.2.2 Global Rotavirus Infections Drug Revenue Market Share by Company (2020-2022)
3.3 Global Rotavirus Infections Drug Sale Price by Company
3.4 Key Manufacturers Rotavirus Infections Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rotavirus Infections Drug Product Location Distribution
3.4.2 Players Rotavirus Infections Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ROTAVIRUS INFECTIONS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Rotavirus Infections Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Rotavirus Infections Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Rotavirus Infections Drug Annual Revenue by Geographic Region
4.2 World Historic Rotavirus Infections Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Rotavirus Infections Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Rotavirus Infections Drug Annual Revenue by Country/Region
4.3 Americas Rotavirus Infections Drug Sales Growth
4.4 APAC Rotavirus Infections Drug Sales Growth
4.5 Europe Rotavirus Infections Drug Sales Growth
4.6 Middle East & Africa Rotavirus Infections Drug Sales Growth
5 AMERICAS
5.1 Americas Rotavirus Infections Drug Sales by Country
5.1.1 Americas Rotavirus Infections Drug Sales by Country (2017-2022)
5.1.2 Americas Rotavirus Infections Drug Revenue by Country (2017-2022)
5.2 Americas Rotavirus Infections Drug Sales by Type
5.3 Americas Rotavirus Infections Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rotavirus Infections Drug Sales by Region
6.1.1 APAC Rotavirus Infections Drug Sales by Region (2017-2022)
6.1.2 APAC Rotavirus Infections Drug Revenue by Region (2017-2022)
6.2 APAC Rotavirus Infections Drug Sales by Type
6.3 APAC Rotavirus Infections Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Rotavirus Infections Drug by Country
7.1.1 Europe Rotavirus Infections Drug Sales by Country (2017-2022)
7.1.2 Europe Rotavirus Infections Drug Revenue by Country (2017-2022)
7.2 Europe Rotavirus Infections Drug Sales by Type
7.3 Europe Rotavirus Infections Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Rotavirus Infections Drug by Country
8.1.1 Middle East & Africa Rotavirus Infections Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Rotavirus Infections Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Rotavirus Infections Drug Sales by Type
8.3 Middle East & Africa Rotavirus Infections Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rotavirus Infections Drug
10.3 Manufacturing Process Analysis of Rotavirus Infections Drug
10.4 Industry Chain Structure of Rotavirus Infections Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rotavirus Infections Drug Distributors
11.3 Rotavirus Infections Drug Customer
12 WORLD FORECAST REVIEW FOR ROTAVIRUS INFECTIONS DRUG BY GEOGRAPHIC REGION
12.1 Global Rotavirus Infections Drug Market Size Forecast by Region
12.1.1 Global Rotavirus Infections Drug Forecast by Region (2023-2028)
12.1.2 Global Rotavirus Infections Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rotavirus Infections Drug Forecast by Type
12.7 Global Rotavirus Infections Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Beijing Minhai Biotechnology Co Ltd
13.1.1 Beijing Minhai Biotechnology Co Ltd Company Information
13.1.2 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product Offered
13.1.3 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Beijing Minhai Biotechnology Co Ltd Main Business Overview
13.1.5 Beijing Minhai Biotechnology Co Ltd Latest Developments
13.2 Bharat Biotech International Ltd
13.2.1 Bharat Biotech International Ltd Company Information
13.2.2 Bharat Biotech International Ltd Rotavirus Infections Drug Product Offered
13.2.3 Bharat Biotech International Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bharat Biotech International Ltd Main Business Overview
13.2.5 Bharat Biotech International Ltd Latest Developments
13.3 Biological E Ltd
13.3.1 Biological E Ltd Company Information
13.3.2 Biological E Ltd Rotavirus Infections Drug Product Offered
13.3.3 Biological E Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Biological E Ltd Main Business Overview
13.3.5 Biological E Ltd Latest Developments
13.4 Curevac AG
13.4.1 Curevac AG Company Information
13.4.2 Curevac AG Rotavirus Infections Drug Product Offered
13.4.3 Curevac AG Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Curevac AG Main Business Overview
13.4.5 Curevac AG Latest Developments
13.5 Medicago Inc
13.5.1 Medicago Inc Company Information
13.5.2 Medicago Inc Rotavirus Infections Drug Product Offered
13.5.3 Medicago Inc Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Medicago Inc Main Business Overview
13.5.5 Medicago Inc Latest Developments
13.6 Nanotherapeutics Inc
13.6.1 Nanotherapeutics Inc Company Information
13.6.2 Nanotherapeutics Inc Rotavirus Infections Drug Product Offered
13.6.3 Nanotherapeutics Inc Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Nanotherapeutics Inc Main Business Overview
13.6.5 Nanotherapeutics Inc Latest Developments
13.7 Serum Institute of India Ltd
13.7.1 Serum Institute of India Ltd Company Information
13.7.2 Serum Institute of India Ltd Rotavirus Infections Drug Product Offered
13.7.3 Serum Institute of India Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Serum Institute of India Ltd Main Business Overview
13.7.5 Serum Institute of India Ltd Latest Developments
13.8 UMN Pharma Inc
13.8.1 UMN Pharma Inc Company Information
13.8.2 UMN Pharma Inc Rotavirus Infections Drug Product Offered
13.8.3 UMN Pharma Inc Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 UMN Pharma Inc Main Business Overview
13.8.5 UMN Pharma Inc Latest Developments
13.9 Wuhan Institute of Biological Products Co Ltd
13.9.1 Wuhan Institute of Biological Products Co Ltd Company Information
13.9.2 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product Offered
13.9.3 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Wuhan Institute of Biological Products Co Ltd Main Business Overview
13.9.5 Wuhan Institute of Biological Products Co Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Rotavirus Infections Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Rotavirus Infections Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of RV-3BB
Table 4. Major Players of RV-625
Table 5. Major Players of UMN-2001
Table 6. Major Players of Rotavac-5C
Table 7. Major Players of Others
Table 8. Global Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Rotavirus Infections Drug Sales Market Share by Type (2017-2022)
Table 10. Global Rotavirus Infections Drug Revenue by Type (2017-2022) & ($ million)
Table 11. Global Rotavirus Infections Drug Revenue Market Share by Type (2017-2022)
Table 12. Global Rotavirus Infections Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Rotavirus Infections Drug Sales Market Share by Application (2017-2022)
Table 15. Global Rotavirus Infections Drug Revenue by Application (2017-2022)
Table 16. Global Rotavirus Infections Drug Revenue Market Share by Application (2017-2022)
Table 17. Global Rotavirus Infections Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Rotavirus Infections Drug Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Rotavirus Infections Drug Sales Market Share by Company (2020-2022)
Table 20. Global Rotavirus Infections Drug Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Rotavirus Infections Drug Revenue Market Share by Company (2020-2022)
Table 22. Global Rotavirus Infections Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Rotavirus Infections Drug Producing Area Distribution and Sales Area
Table 24. Players Rotavirus Infections Drug Products Offered
Table 25. Rotavirus Infections Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Rotavirus Infections Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Rotavirus Infections Drug Sales Market Share Geographic Region (2017-2022)
Table 30. Global Rotavirus Infections Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Rotavirus Infections Drug Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Rotavirus Infections Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Rotavirus Infections Drug Sales Market Share by Country/Region (2017-2022)
Table 34. Global Rotavirus Infections Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Rotavirus Infections Drug Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Rotavirus Infections Drug Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Rotavirus Infections Drug Sales Market Share by Country (2017-2022)
Table 38. Americas Rotavirus Infections Drug Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Rotavirus Infections Drug Revenue Market Share by Country (2017-2022)
Table 40. Americas Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Rotavirus Infections Drug Sales Market Share by Type (2017-2022)
Table 42. Americas Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Rotavirus Infections Drug Sales Market Share by Application (2017-2022)
Table 44. APAC Rotavirus Infections Drug Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Rotavirus Infections Drug Sales Market Share by Region (2017-2022)
Table 46. APAC Rotavirus Infections Drug Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Rotavirus Infections Drug Revenue Market Share by Region (2017-2022)
Table 48. APAC Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Rotavirus Infections Drug Sales Market Share by Type (2017-2022)
Table 50. APAC Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Rotavirus Infections Drug Sales Market Share by Application (2017-2022)
Table 52. Europe Rotavirus Infections Drug Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Rotavirus Infections Drug Sales Market Share by Country (2017-2022)
Table 54. Europe Rotavirus Infections Drug Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Rotavirus Infections Drug Revenue Market Share by Country (2017-2022)
Table 56. Europe Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Rotavirus Infections Drug Sales Market Share by Type (2017-2022)
Table 58. Europe Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Rotavirus Infections Drug Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Rotavirus Infections Drug Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Rotavirus Infections Drug Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Rotavirus Infections Drug Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Rotavirus Infections Drug Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Rotavirus Infections Drug Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Rotavirus Infections Drug Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Rotavirus Infections Drug
Table 69. Key Market Challenges & Risks of Rotavirus Infections Drug
Table 70. Key Industry Trends of Rotavirus Infections Drug
Table 71. Rotavirus Infections Drug Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Rotavirus Infections Drug Distributors List
Table 74. Rotavirus Infections Drug Customer List
Table 75. Global Rotavirus Infections Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Rotavirus Infections Drug Sales Market Forecast by Region
Table 77. Global Rotavirus Infections Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Rotavirus Infections Drug Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Rotavirus Infections Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Rotavirus Infections Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Rotavirus Infections Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Rotavirus Infections Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Rotavirus Infections Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Rotavirus Infections Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Rotavirus Infections Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Rotavirus Infections Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Rotavirus Infections Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Rotavirus Infections Drug Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Rotavirus Infections Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Rotavirus Infections Drug Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Rotavirus Infections Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Rotavirus Infections Drug Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Rotavirus Infections Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Rotavirus Infections Drug Revenue Market Share Forecast by Application (2023-2028)
Table 95. Beijing Minhai Biotechnology Co Ltd Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product Offered
Table 97. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Beijing Minhai Biotechnology Co Ltd Main Business
Table 99. Beijing Minhai Biotechnology Co Ltd Latest Developments
Table 100. Bharat Biotech International Ltd Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Bharat Biotech International Ltd Rotavirus Infections Drug Product Offered
Table 102. Bharat Biotech International Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Bharat Biotech International Ltd Main Business
Table 104. Bharat Biotech International Ltd Latest Developments
Table 105. Biological E Ltd Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Biological E Ltd Rotavirus Infections Drug Product Offered
Table 107. Biological E Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Biological E Ltd Main Business
Table 109. Biological E Ltd Latest Developments
Table 110. Curevac AG Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Curevac AG Rotavirus Infections Drug Product Offered
Table 112. Curevac AG Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Curevac AG Main Business
Table 114. Curevac AG Latest Developments
Table 115. Medicago Inc Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Medicago Inc Rotavirus Infections Drug Product Offered
Table 117. Medicago Inc Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Medicago Inc Main Business
Table 119. Medicago Inc Latest Developments
Table 120. Nanotherapeutics Inc Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. Nanotherapeutics Inc Rotavirus Infections Drug Product Offered
Table 122. Nanotherapeutics Inc Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Nanotherapeutics Inc Main Business
Table 124. Nanotherapeutics Inc Latest Developments
Table 125. Serum Institute of India Ltd Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. Serum Institute of India Ltd Rotavirus Infections Drug Product Offered
Table 127. Serum Institute of India Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Serum Institute of India Ltd Main Business
Table 129. Serum Institute of India Ltd Latest Developments
Table 130. UMN Pharma Inc Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. UMN Pharma Inc Rotavirus Infections Drug Product Offered
Table 132. UMN Pharma Inc Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. UMN Pharma Inc Main Business
Table 134. UMN Pharma Inc Latest Developments
Table 135. Wuhan Institute of Biological Products Co Ltd Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 136. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product Offered
Table 137. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Wuhan Institute of Biological Products Co Ltd Main Business
Table 139. Wuhan Institute of Biological Products Co Ltd Latest Developments
Table 1. Rotavirus Infections Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Rotavirus Infections Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of RV-3BB
Table 4. Major Players of RV-625
Table 5. Major Players of UMN-2001
Table 6. Major Players of Rotavac-5C
Table 7. Major Players of Others
Table 8. Global Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Rotavirus Infections Drug Sales Market Share by Type (2017-2022)
Table 10. Global Rotavirus Infections Drug Revenue by Type (2017-2022) & ($ million)
Table 11. Global Rotavirus Infections Drug Revenue Market Share by Type (2017-2022)
Table 12. Global Rotavirus Infections Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Rotavirus Infections Drug Sales Market Share by Application (2017-2022)
Table 15. Global Rotavirus Infections Drug Revenue by Application (2017-2022)
Table 16. Global Rotavirus Infections Drug Revenue Market Share by Application (2017-2022)
Table 17. Global Rotavirus Infections Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Rotavirus Infections Drug Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Rotavirus Infections Drug Sales Market Share by Company (2020-2022)
Table 20. Global Rotavirus Infections Drug Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Rotavirus Infections Drug Revenue Market Share by Company (2020-2022)
Table 22. Global Rotavirus Infections Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Rotavirus Infections Drug Producing Area Distribution and Sales Area
Table 24. Players Rotavirus Infections Drug Products Offered
Table 25. Rotavirus Infections Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Rotavirus Infections Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Rotavirus Infections Drug Sales Market Share Geographic Region (2017-2022)
Table 30. Global Rotavirus Infections Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Rotavirus Infections Drug Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Rotavirus Infections Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Rotavirus Infections Drug Sales Market Share by Country/Region (2017-2022)
Table 34. Global Rotavirus Infections Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Rotavirus Infections Drug Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Rotavirus Infections Drug Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Rotavirus Infections Drug Sales Market Share by Country (2017-2022)
Table 38. Americas Rotavirus Infections Drug Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Rotavirus Infections Drug Revenue Market Share by Country (2017-2022)
Table 40. Americas Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Rotavirus Infections Drug Sales Market Share by Type (2017-2022)
Table 42. Americas Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Rotavirus Infections Drug Sales Market Share by Application (2017-2022)
Table 44. APAC Rotavirus Infections Drug Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Rotavirus Infections Drug Sales Market Share by Region (2017-2022)
Table 46. APAC Rotavirus Infections Drug Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Rotavirus Infections Drug Revenue Market Share by Region (2017-2022)
Table 48. APAC Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Rotavirus Infections Drug Sales Market Share by Type (2017-2022)
Table 50. APAC Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Rotavirus Infections Drug Sales Market Share by Application (2017-2022)
Table 52. Europe Rotavirus Infections Drug Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Rotavirus Infections Drug Sales Market Share by Country (2017-2022)
Table 54. Europe Rotavirus Infections Drug Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Rotavirus Infections Drug Revenue Market Share by Country (2017-2022)
Table 56. Europe Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Rotavirus Infections Drug Sales Market Share by Type (2017-2022)
Table 58. Europe Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Rotavirus Infections Drug Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Rotavirus Infections Drug Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Rotavirus Infections Drug Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Rotavirus Infections Drug Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Rotavirus Infections Drug Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Rotavirus Infections Drug Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Rotavirus Infections Drug Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Rotavirus Infections Drug Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Rotavirus Infections Drug Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Rotavirus Infections Drug
Table 69. Key Market Challenges & Risks of Rotavirus Infections Drug
Table 70. Key Industry Trends of Rotavirus Infections Drug
Table 71. Rotavirus Infections Drug Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Rotavirus Infections Drug Distributors List
Table 74. Rotavirus Infections Drug Customer List
Table 75. Global Rotavirus Infections Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Rotavirus Infections Drug Sales Market Forecast by Region
Table 77. Global Rotavirus Infections Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Rotavirus Infections Drug Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Rotavirus Infections Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Rotavirus Infections Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Rotavirus Infections Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Rotavirus Infections Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Rotavirus Infections Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Rotavirus Infections Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Rotavirus Infections Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Rotavirus Infections Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Rotavirus Infections Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Rotavirus Infections Drug Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Rotavirus Infections Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Rotavirus Infections Drug Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Rotavirus Infections Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Rotavirus Infections Drug Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Rotavirus Infections Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Rotavirus Infections Drug Revenue Market Share Forecast by Application (2023-2028)
Table 95. Beijing Minhai Biotechnology Co Ltd Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product Offered
Table 97. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Beijing Minhai Biotechnology Co Ltd Main Business
Table 99. Beijing Minhai Biotechnology Co Ltd Latest Developments
Table 100. Bharat Biotech International Ltd Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Bharat Biotech International Ltd Rotavirus Infections Drug Product Offered
Table 102. Bharat Biotech International Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Bharat Biotech International Ltd Main Business
Table 104. Bharat Biotech International Ltd Latest Developments
Table 105. Biological E Ltd Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Biological E Ltd Rotavirus Infections Drug Product Offered
Table 107. Biological E Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Biological E Ltd Main Business
Table 109. Biological E Ltd Latest Developments
Table 110. Curevac AG Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Curevac AG Rotavirus Infections Drug Product Offered
Table 112. Curevac AG Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Curevac AG Main Business
Table 114. Curevac AG Latest Developments
Table 115. Medicago Inc Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Medicago Inc Rotavirus Infections Drug Product Offered
Table 117. Medicago Inc Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Medicago Inc Main Business
Table 119. Medicago Inc Latest Developments
Table 120. Nanotherapeutics Inc Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. Nanotherapeutics Inc Rotavirus Infections Drug Product Offered
Table 122. Nanotherapeutics Inc Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Nanotherapeutics Inc Main Business
Table 124. Nanotherapeutics Inc Latest Developments
Table 125. Serum Institute of India Ltd Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. Serum Institute of India Ltd Rotavirus Infections Drug Product Offered
Table 127. Serum Institute of India Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Serum Institute of India Ltd Main Business
Table 129. Serum Institute of India Ltd Latest Developments
Table 130. UMN Pharma Inc Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. UMN Pharma Inc Rotavirus Infections Drug Product Offered
Table 132. UMN Pharma Inc Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. UMN Pharma Inc Main Business
Table 134. UMN Pharma Inc Latest Developments
Table 135. Wuhan Institute of Biological Products Co Ltd Basic Information, Rotavirus Infections Drug Manufacturing Base, Sales Area and Its Competitors
Table 136. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product Offered
Table 137. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Wuhan Institute of Biological Products Co Ltd Main Business
Table 139. Wuhan Institute of Biological Products Co Ltd Latest Developments
LIST OF FIGURES
Figure 1. Picture of Rotavirus Infections Drug
Figure 2. Rotavirus Infections Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rotavirus Infections Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Rotavirus Infections Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Rotavirus Infections Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of RV-3BB
Figure 10. Product Picture of RV-625
Figure 11. Product Picture of UMN-2001
Figure 12. Product Picture of Rotavac-5C
Figure 13. Product Picture of Others
Figure 14. Global Rotavirus Infections Drug Sales Market Share by Type in 2021
Figure 15. Global Rotavirus Infections Drug Revenue Market Share by Type (2017-2022)
Figure 16. Rotavirus Infections Drug Consumed in Clinic
Figure 17. Global Rotavirus Infections Drug Market: Clinic (2017-2022) & (K Pcs)
Figure 18. Rotavirus Infections Drug Consumed in Hospital
Figure 19. Global Rotavirus Infections Drug Market: Hospital (2017-2022) & (K Pcs)
Figure 20. Rotavirus Infections Drug Consumed in Others
Figure 21. Global Rotavirus Infections Drug Market: Others (2017-2022) & (K Pcs)
Figure 22. Global Rotavirus Infections Drug Sales Market Share by Application (2017-2022)
Figure 23. Global Rotavirus Infections Drug Revenue Market Share by Application in 2021
Figure 24. Rotavirus Infections Drug Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Rotavirus Infections Drug Revenue Market Share by Company in 2021
Figure 26. Global Rotavirus Infections Drug Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Rotavirus Infections Drug Revenue Market Share by Geographic Region in 2021
Figure 28. Global Rotavirus Infections Drug Sales Market Share by Region (2017-2022)
Figure 29. Global Rotavirus Infections Drug Revenue Market Share by Country/Region in 2021
Figure 30. Americas Rotavirus Infections Drug Sales 2017-2022 (K Pcs)
Figure 31. Americas Rotavirus Infections Drug Revenue 2017-2022 ($ Millions)
Figure 32. APAC Rotavirus Infections Drug Sales 2017-2022 (K Pcs)
Figure 33. APAC Rotavirus Infections Drug Revenue 2017-2022 ($ Millions)
Figure 34. Europe Rotavirus Infections Drug Sales 2017-2022 (K Pcs)
Figure 35. Europe Rotavirus Infections Drug Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Rotavirus Infections Drug Sales 2017-2022 (K Pcs)
Figure 37. Middle East & Africa Rotavirus Infections Drug Revenue 2017-2022 ($ Millions)
Figure 38. Americas Rotavirus Infections Drug Sales Market Share by Country in 2021
Figure 39. Americas Rotavirus Infections Drug Revenue Market Share by Country in 2021
Figure 40. United States Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Rotavirus Infections Drug Sales Market Share by Region in 2021
Figure 45. APAC Rotavirus Infections Drug Revenue Market Share by Regions in 2021
Figure 46. China Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Rotavirus Infections Drug Sales Market Share by Country in 2021
Figure 53. Europe Rotavirus Infections Drug Revenue Market Share by Country in 2021
Figure 54. Germany Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Rotavirus Infections Drug Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Rotavirus Infections Drug Revenue Market Share by Country in 2021
Figure 61. Egypt Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Rotavirus Infections Drug in 2021
Figure 67. Manufacturing Process Analysis of Rotavirus Infections Drug
Figure 68. Industry Chain Structure of Rotavirus Infections Drug
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 1. Picture of Rotavirus Infections Drug
Figure 2. Rotavirus Infections Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rotavirus Infections Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Rotavirus Infections Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Rotavirus Infections Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of RV-3BB
Figure 10. Product Picture of RV-625
Figure 11. Product Picture of UMN-2001
Figure 12. Product Picture of Rotavac-5C
Figure 13. Product Picture of Others
Figure 14. Global Rotavirus Infections Drug Sales Market Share by Type in 2021
Figure 15. Global Rotavirus Infections Drug Revenue Market Share by Type (2017-2022)
Figure 16. Rotavirus Infections Drug Consumed in Clinic
Figure 17. Global Rotavirus Infections Drug Market: Clinic (2017-2022) & (K Pcs)
Figure 18. Rotavirus Infections Drug Consumed in Hospital
Figure 19. Global Rotavirus Infections Drug Market: Hospital (2017-2022) & (K Pcs)
Figure 20. Rotavirus Infections Drug Consumed in Others
Figure 21. Global Rotavirus Infections Drug Market: Others (2017-2022) & (K Pcs)
Figure 22. Global Rotavirus Infections Drug Sales Market Share by Application (2017-2022)
Figure 23. Global Rotavirus Infections Drug Revenue Market Share by Application in 2021
Figure 24. Rotavirus Infections Drug Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Rotavirus Infections Drug Revenue Market Share by Company in 2021
Figure 26. Global Rotavirus Infections Drug Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Rotavirus Infections Drug Revenue Market Share by Geographic Region in 2021
Figure 28. Global Rotavirus Infections Drug Sales Market Share by Region (2017-2022)
Figure 29. Global Rotavirus Infections Drug Revenue Market Share by Country/Region in 2021
Figure 30. Americas Rotavirus Infections Drug Sales 2017-2022 (K Pcs)
Figure 31. Americas Rotavirus Infections Drug Revenue 2017-2022 ($ Millions)
Figure 32. APAC Rotavirus Infections Drug Sales 2017-2022 (K Pcs)
Figure 33. APAC Rotavirus Infections Drug Revenue 2017-2022 ($ Millions)
Figure 34. Europe Rotavirus Infections Drug Sales 2017-2022 (K Pcs)
Figure 35. Europe Rotavirus Infections Drug Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Rotavirus Infections Drug Sales 2017-2022 (K Pcs)
Figure 37. Middle East & Africa Rotavirus Infections Drug Revenue 2017-2022 ($ Millions)
Figure 38. Americas Rotavirus Infections Drug Sales Market Share by Country in 2021
Figure 39. Americas Rotavirus Infections Drug Revenue Market Share by Country in 2021
Figure 40. United States Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Rotavirus Infections Drug Sales Market Share by Region in 2021
Figure 45. APAC Rotavirus Infections Drug Revenue Market Share by Regions in 2021
Figure 46. China Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Rotavirus Infections Drug Sales Market Share by Country in 2021
Figure 53. Europe Rotavirus Infections Drug Revenue Market Share by Country in 2021
Figure 54. Germany Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Rotavirus Infections Drug Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Rotavirus Infections Drug Revenue Market Share by Country in 2021
Figure 61. Egypt Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Rotavirus Infections Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Rotavirus Infections Drug in 2021
Figure 67. Manufacturing Process Analysis of Rotavirus Infections Drug
Figure 68. Industry Chain Structure of Rotavirus Infections Drug
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
